Shareholders Foundation, Inc.

NYSE:MMS Shareholder Alert: Lawsuit Against MAXIMUS, Inc. Filed

A lawsuit was filed on behalf of investors in MAXIMUS, Inc. (NYSE:MMS) shares over alleged securities laws violations.


San Diego, CA -- (SBWIRE) -- 08/30/2017 -- An investor in NYSE:MMS shares filed a lawsuit over alleged violations of Federal Securities Laws by MAXIMUS, Inc

Investors who purchased shares of MAXIMUS, Inc. (NYSE:MMS) have certain options and for certain investors are short and strict deadlines running. Deadline: October 6, 2017. NYSE:MMS investors should contact the Shareholders Foundation at or call 858-779-1554.

According to the complaint the plaintiff alleges on behalf of purchasers of MAXIMUS, Inc. (NYSE:MMS) common shares between October 30, 2014 and February 3, 2016, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between October 30, 2014 and February 3, 2016, the Defendants made false and/or misleading statements and/or failed to disclose that in obtaining the HAAS contract, Maximus set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments, that throughout the HAAS contract, Maximus was struggling to recruit, train and ramp-up new health care staff to perform the assessments, that the inability to meet its target number of healthcare recruits and target number of assessments, meant Maximus would not earn the performance-based incentive fees from the HAAS contract, and that consequently, Defendants' statements about the Company, its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue the Company expected the contract to contribute, lacked a reasonable basis when made.

Those who purchased shares of MAXIMUS, Inc. (NYSE:MMS) have certain options and should contact the Shareholders Foundation.

Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739